Providers: Face Masks Outside Hospital Settings, Counseling Patients on COVID-19
In this second installment of his interview, Howard Koh, MD, MPH, discusses the importance of providers and health care workers wearing face masks during their interactions with patients.
Watch
Ebola Outbreak Reaches 60 Patients in Mbandaka, DRC
How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?
Calling Upon Florida and the Nation to Require Face Masks
A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.
Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Loss of Life From Antibiotic Resistance May Surpass Cancer By 2050
Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.
A Timeline to Heparin in COVID-19 Patients
Perspective on how the anticoagulant could progress to human trials and potentially, marketing use for coronavirus prevention.
Could Heparin Prevent Coronavirus Infection?
A discussion with an RPI investigator after promising early findings.
COVID-19 Pandemic Threatens Global Infectious Disease Control Progress
A modeling study from Imperial College shows the COVID-19 pandemic may have significant effect on mortality among other infectious disease patients.
Applying African Ebola Response Experience to the Coronavirus Pandemic
West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.
The Dangers of Respiratory Droplets to Frontline Health Care Providers
A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.
How Will Coronavirus Impact HIV, TB, & Malaria in Developing African Countries?
A modeling study from Imperial College shows the COVID-19 pandemic may require balancing with other infectious disease priorities.
Who Should be Wearing Face Masks?
Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.
Why is Ebola Endemic to the DRC?
In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.
Getting Younger People on PrEP
Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.
Complicating the Coronavirus Lockdown Debate
A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.
Unmet HIV Therapy Needs, Cure Research, and Virtual Conferences
In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.
The Social Hurdles of HIV Awareness and Prevention
How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.
Insights into Vesatolimod
Gilead provides some important information on this investigational therapy.
Why Fewer At-Risk Men Take HIV PrEP
A study looking at PrEP population obstacles shows men who have sex with men are more likely to not seek out information nor access to prophylaxis.
HIV Screening: Are Primary Care Physicians Following CDC Guidelines?
Dr. Marc Pitasi, epidemiologist, discusses facilitators of routine HIV screening among primary care physicians.
How California is Improving PrEP Access
A discussion around new data presented at AIDS 2020 which shows statewide strategies are breaking down barriers.
Long-Term PrEP Continuum of Care Patterns
Uncovering interesting findings regarding patients' PrEP regimen.
COVID-19 vs HIV: How the Epidemics Compare
How much does the current virus crisis share in common with early HIV outbreak scare?
The Burden of Multidrug-Resistant HIV
With fostemsavir now available for patients with few options, an expert discusses what challenges MDR-HIV patients face in their care.
Fostemsavir Benefits Multi-Drug Resistant HIV
A look at the BRIGHTE study data which evidenced the recently FDA-approved add-on agent.
Gaining Insights into Islatravir and Doravirine
Carey Hwang, MD, PhD, executive director and product development lead, Global Clinical Development of Infectious Disease at Merck spoke with Contagion® regarding the therapies and went further into depth about the studies.
The Epidemiology of MIS-C
How the inflammatory-based syndrome is affecting US children during the COVID-19 pandemic.
Growing US Cases of MIS-C
A discussion on how the pediatric inflammatory syndrome has begun to affect the US months into the pandemic.
Are Pregnant Women at Worse Coronavirus Risk?
A discussion with a Yale expert on what new CDC data shows.
Open Questions in Coronavirus Immunology
Judith Feinberg, MD, FIDSA, describes ongoing investigation into the immune response from COVID-19.
